Bristol Myers Squibb Partners with Anthropic to Enhance Drug Development
Bristol Myers Squibb has entered a strategic partnership with Anthropic to utilize AI in drug manufacturing and quality assurance, marking a significant commitment to AI in pharmaceuticals.
More from this archive
Hark Secures $700M Series A to Create Universal AI Interface
Hark raises $700 million in Series A funding, aiming to launch a universal AI personal assistant. With a…
Telcos Shifting Towards Token-Metered AI Services with NVIDIA
Telecommunications companies are adopting NVIDIA’s Cloud Partner architecture to evolve into token factories, providing AI services measured by…
Polyend’s Endless Pedal Merges AI and Guitar Effects, with Caveats
Polyend's Endless pedal uses AI to create custom guitar effects, offering a unique approach to sound design. However,…
AMD Commits Over $10B to Enhance AI Chip Production in Taiwan
AMD's $10 billion investment in Taiwan signals a strategic push to increase AI chip production, addressing escalating global…
The archive
sorted by latest
NVIDIA Triumphs at COMPUTEX 2026 with Multiple Awards for AI Innovations
GPUBeat Desk · 1 min
AMD’s EPYC Venice Begins Production, Promises Major Performance Boost
GPUBeat Desk · 2 min
ChatOn AI App Offers Yearly Access to Top AI Models for $30
GPUBeat Desk · 2 min
Spotify Introduces AI-Generated Podcasts with New Studio App
GPUBeat Desk · 2 min
Anthropic Set for First Profitable Quarter Amid AI Surge
GPUBeat Desk · 2 min